Enlivex Therapeutics (ENLV) Earnings Date & Reports

Industry: @Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

ENLV is expected to report earnings to rise 62.50% to -19 cents per share on December 02

Enlivex Therapeutics ENLV Stock Earnings Reports

Q3'24

Est.

$-0.19

Q2'24

Beat

by $0.03

Q1'24

Est.

$-0.25

Q4'23

Missed

by $0.21

Q3'23

Est.

$-0.32

The last earnings report on August 19 showed earnings per share of -11 cents, beating the estimate of -15 cents. With 206.45K shares outstanding, the current market capitalization sits at 27.40M.

View a ticker or compare two or three

Compare

ENLV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ENLV
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Specialties

Address

14 Einstein Street

Phone

+972 26208072

Employees

Web

https://www.enlivex.com